Navigation Links
Biovista Announces the Appointment of Clifford H. Farrah to its Advisory Board
Date:7/13/2010

CHARLOTTESVILLE, Virginia, July 13, 2010 /PRNewswire/ -- Biovista announced today the appointment of Mr. Clifford H. Farrah, President and Chairman of The Beacon Group, to its Advisory Board.

"We are very excited to have Cliff join our Advisory Board," said Aris Persidis, President of Biovista. "Cliff brings a wealth of direct commercial development experience in the healthcare and biotech market that will be invaluable to us as we grow Biovista," he added.

"Biovista is a new generation biotechnology company with unique technology and capabilities," said Mr. Farrah. "It's rare that you get the opportunity to help a company lead in the new order of drug discovery and development. Biovista is offering a disruptive, rigorous and efficient approach to a costly process, and I am excited to participate in its future."

About the Beacon Group (http://www.tbg-online.com):

The Beacon Group is a strategy consulting firm providing guidance to organizations on their most critical business issues. With a clear focus on achieving top-line growth through both organic and inorganic means, Beacon's output is designed to have a direct impact on client profitability. Healthcare practice base includes Fortune 100 biotech, pharmaceutical, medical device and diagnostics companies.

About Biovista (http://www.biovista.com):

Biovista is a privately held biotechnology company that finds novel uses for existing drugs, and profiles their side effects using their mechanism of action. Biovista is developing its own pipeline of drugs in multiple sclerosis, epilepsy, specific cancers and auto-immune diseases. Also, Biovista is collaborating with the FDA on prediction of adverse events, and with biopharmaceutical companies on indication expansion and de-risking of their portfolios.

    For further information please contact:

    Dr. Aris Persidis
    Biovista, Inc.
    arisp@biovista.com
    +1-434-242-6514



'/>"/>
SOURCE Biovista
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biovista Inc. and FDA to Collaborate on a Medication Safety Initiative
2. Biovista Inc. Named Top Innovator in Life Sciences
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
(Date:2/23/2017)...  Genesis Healthcare Services has merged with Hospice Cloud, ... Bill Monast , President and CEO of Hospice ... Feltman , executives with Home Health Depot, Inc., the ... This acquisition helps Hospice Cloud maintain its position ... medical equipment (DME) solutions for the hospice industry. ...
(Date:2/23/2017)... Corp. (NYSE: NVRO), a global medical device company that is ... today reported financial results for the three months and full ... & Highlights: Achieved revenue of $228.5 million ... reported, over the prior year U.S. revenue of ... prior year International revenue of $55.2 million ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... Healthcare Associates of McKinney announced today that ... at 8080 State Highway 121, Suite 210, McKinney, Texas 75070. It is in ... , As the practice has grown, the need for more space has been paramount. ...
(Date:2/24/2017)... ... 24, 2017 , ... With ProGlass Prism users now have the ability to ... control over position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position ... With ProGlass Prism users are given the tools and effects to generate a ...
(Date:2/24/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has published a ... an astounding statement when he says that the entire Bible was written for the ... times so plainly that anyone should be able to see the time period. He ...
(Date:2/24/2017)... ... ... Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he will ... the Management Committee when IFN was originally formed in 2002 where he was ultimately ... of the business plan. He became the first paid employee of IFN in ...
(Date:2/24/2017)... Lawn, NJ (PRWEB) , ... February 24, 2017 ... ... with robust marketing services, which specializes in thought leadership , media relations, ... marketing campaigns and services that will be powered through Act-On, an intuitive marketing ...
Breaking Medicine News(10 mins):